Form 4: Swan Sit Acquires Restricted Stock Equivalents in Edgewell Personal Care Co

Director Swan Sit acquired 4,999 restricted stock equivalents in Edgewell Personal Care Co on February 6, 2025, convertible into common stock.

Summary

• On February 6, 2025, Swan Sit, a director of Edgewell Personal Care Co, acquired 4,999 restricted stock equivalents.
• These restricted stock equivalents are convertible into shares of Edgewell Common Stock.
• The conversion occurs the day before the next annual meeting of shareholders, unless Sit defers conversion until termination of service on Edgewell's Board of Directors.
• Following the transaction, Sit directly owns 4,999 restricted stock equivalents.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing a transaction of restricted stock equivalents. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The restricted stock equivalents will convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders, unless the Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors.

Industry Context

This Form 4 filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the holdings and transactions of company insiders, allowing investors to monitor potential alignment of interests between management and shareholders.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider ownership.
• The acquisition of restricted stock equivalents aligns the director's interests with those of the shareholders.

Key Dates

Keywords

Edgewell Personal Care Co, Swan Sit, restricted stock equivalents, Form 4, beneficial ownership, director, EPC